Conferences Addition Therapeutics is attending in 2026
Addition Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: ESGCT 2026 (on the program) and Meeting on the Mesa 2026 (on the attendee list). Addition Therapeutics develops PRINT, an all-RNA platform delivered by lipid nanoparticles that uses an R2 retrotransposase to insert therapeutic genes durably. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
ESGCT 33rd Annual CongressEurope’s gene & cell therapy researchersOfficial site |
Hamburg, Germany ~2.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 2 posters, 1 oral abstract Attendee mix: Mostly academic; gene and cell therapy PIs, postdocs and clinicians, strong biotech and CDMO presence
Attending
|
Open the guide Search and filter attendees |
Cell & Gene Meeting on the Mesa 2026Cell & gene therapy dealmakersOfficial site |
Past Phoenix, AZ ~1.5k attendees | On the attendee listNo booth or sponsorship in the organizer’s published lists Listed in the Meeting on the Mesa 2026 guide; no booth or program details yet
Attendee mix: Almost entirely industry; CGT CEOs, BD, investors and manufacturing partners, few researchers
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Addition Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Addition Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!